Aortic Stenosis: Multimedia

References

1. [Guideline] Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. May 21 2003;289(19):2560-72. [Medline].

2. Moura LM, Ramos SF, Zamorano JL, Barros IM, Azevedo LF, Rocha-Gonçalves F. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol. Feb 6 2007;49(5):554-61. [Medline].

3. Zajarias A, Cribier A. Outcomes and safety of percutaneous aortic valve replacement. Journal of the American College of Cardiology. May 2009;53:1829-36. [Medline].

4. [Guideline] Nishimura RA, Carabello BA, Faxon DP, et al. ACC/AHA 2008 Guideline Update on Valvular Heart Disease: Focused Update on Infective Endocarditis: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. August 2008;52:676-85. [Medline].

5. Agarwal A, Kini AS, Attanti S, et al. Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. Am J Cardiol. Jan 1 2005;95(1):43-7. [Medline].

6. Bauer F, Eltchaninoff H, Tron C, et al. Acute improvement in global and regional left ventricular systolic function after percutaneous heart valve implantation in patients with symptomatic aortic stenosis. Circulation. Sep 14 2004;110(11):1473-6. [Medline].

7. Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation. May 2004;109:2302-8. [Medline].

8. Bonow RO, Carabello B, de Leon AC, et al. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. Nov 3 1998;98(18):1949-84. [Medline].

9. Braunwald E. Heart disease: a textbook of cardiovascular medicine. In: Braunwald E, ed. Aortic Stenosis. 4^th ed. Philadelphia, Pa: WB Saunders; 1992:1035-43.

10. Connolly HM, Oh JK, Orszulak TA, et al. Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction. Prognostic indicators. Circulation. May 20 1997;95(10):2395-400. [Medline].

11. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. Dec 10 2002;106(24):3006-8. [Medline].

12. Frank S, Johnson A, Ross J Jr. Natural history of valvular aortic stenosis. Br Heart J. Jan 1973;35(1):41-6. [Medline].

13. Hanzel GS, Harrity PJ, Schreiber TL, O'Neill WW. Retrograde percutaneous aortic valve implantation for critical aortic stenosis. Catheter Cardiovasc Interv. Mar 2005;64(3):322-6. [Medline].

14. Hughes BR, Chahoud G, Mehta JL. Aortic stenosis: is it simply a degenerative process or an active atherosclerotic process?. Clin Cardiol. Mar 2005;28(3):111-4. [Medline].

15. Messika-Zeitoun D, Aubry MC, Detaint D, et al. Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography. Circulation. Jul 20 2004;110(3):356-62. [Medline].

16. Novaro GM. Electron beam computed tomography: the latest "stethoscope" for calcific aortic valve disease. Mayo Clin Proc. Oct 2004;79(10):1239-41. [Medline].

17. O'Rourke RA. Aortic valve stenosis: a common clinical entity. Curr Probl Cardiol. Aug 1998;23(8):434-71. [Medline].

18. Otto CM. Aortic stenosis and hyperlipidemia: establishing a cause-effect relationship. Am Heart J. May 2004;147(5):761-3. [Medline].

19. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation. May 6 1997;95(9):2262-70. [Medline].

20. Passik CS, Ackermann DM, Pluth JR, Edwards WD. Temporal changes in the causes of aortic stenosis: a surgical pathologic study of 646 cases. Mayo Clin Proc. Feb 1987;62(2):119-23. [Medline].

21. Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol. Apr 1990;15(5):1012-7. [Medline].

22. Prasad Y, Bhalodkar NC. Aortic sclerosis--a marker of coronary atherosclerosis. Clin Cardiol. Dec 2004;27(12):671-3. [Medline].

23. Rahimtoola SH. The year in valvular heart disease. J Am Coll Cardiol. Jan 4 2005;45(1):111-22. [Medline].

24. Rajamannan NM, Otto CM. Targeted therapy to prevent progression of calcific aortic stenosis. Circulation. Sep 7 2004;110(10):1180-2. [Medline].

25. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation. Sep 7 2004;110(10):1291-5. [Medline].

26. Selzer A. Changing aspects of the natural history of valvular aortic stenosis. N Engl J Med. Jul 9 1987;317(2):91-8. [Medline].

27. Vahanian A, Palacios IF. Percutaneous approaches to valvular disease. Circulation. Apr 6 2004;109(13):1572-9. [Medline].

Further Reading

Keywords

aortic stenosis, AS, valvular aortic stenosis, valvular AS, aorta stenosis, aortic valve surgery, heart failure, syncope, angina pectoris, pulsus parvus et tardus, heart valve obstruction, aortic obstruction, aortic valve obstruction, aortic valve replacement, AVR, sudden cardiac death, SCD, calcific embolization, infective endocarditis

Contributor Information and Disclosures

Author

John A McPherson, MD, FACC, FSCAI, Assistant Professor of Medicine, Division of Cardiovascular Medicine, Medical Director of Cardiovascular Intensive Care Unit, Vanderbilt Heart and Vascular Institute
John A McPherson, MD, FACC, FSCAI is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American Heart Association, Society for Cardiac Angiography and Interventions, Society of Critical Care Medicine, and Tennessee Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Alan D Forker, MD, Professor of Medicine, Program Director of Cardiovascular Fellowship, University of Missouri at Kansas City School of Medicine; Director, Outpatient Lipid Diabetes Research Center, MidAmerica Heart Institute of St Luke's Hospital
Alan D Forker, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American College of Physicians, American Heart Association, American Medical Association, American Society of Hypertension, and Phi Beta Kappa
Disclosure: Research Grant Grant/research funds Hospital contracts to do research; I am a hospital employee with no personal profit; Speakers Bureau Honoraria Speaking and teaching

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Steven J Compton, MD, FACC, FACP, Director of Cardiac Electrophysiology, Alaska Heart Institute, Providence and Alaska Regional Hospitals
Steven J Compton, MD, FACC, FACP is a member of the following medical societies: Alaska State Medical Association, American College of Cardiology, and American College of Physicians
Disclosure: Nothing to disclose.

CME Editor

Amer Suleman, MD, Consultant in Electrophysiology and Cardiovascular Medicine, Department of Internal Medicine, Division of Cardiology, Medical City Dallas Hospital
Amer Suleman, MD is a member of the following medical societies: American College of Physicians, American Heart Association, American Institute of Stress, American Society of Hypertension, Federation of American Societies for Experimental Biology, Royal Society of Medicine, and Society of Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

Chief Editor

Richard A Lange, MD, Professor and Executive Vice Chairman, Department of Medicine, University of Texas Health Science Center at San Antonio
Richard A Lange, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American Heart Association, and Association of Subspecialty Professors
Disclosure: Nothing to disclose.